Analysts

This pharma stock “is beating everything”, investor says

BNN Bloomberg Market Call guest Colin Cieszynski said Teva Pharmaceutical Industries (Teva Pharmaceutical Industries Stock Quote, Chart, News, Analysts, Financials NYSE:TEVA) has emerged as a standout performer amid a broader rotation into drug stocks, driven by strong price momentum and relative strength rather than company-specific catalysts. Speaking on the Jan. 9 program, the SIA Wealth […]

Analysts png

Should you sell your Kraken Robotics stock?

Citing increased valuation risk and a more balanced near-term risk-reward profile following a sharp run-up in the shares, National Bank Financial analyst Mike Stevens downgraded Kraken Robotics (Kraken Stock Quote, Chart, News, Analysts, Financials TSXV:PNG) to “Sector Perform” from “Outperform” on Jan. 15. At the same time, Stevens raised his target price to $8.75 from […]

Get Stock Picks from the Pros.
In your Inbox.

Analysts csu

Constellation Software gets price target raise at Cormark

August 6, 2014

Constellation Software’s (TSX:CSU) second quarter showed a return to form, say Cormark analyst...

Analysts Life Sciences tos

TS03 Shares Spike On Anticipation of FDA Approval

August 6, 2014

Shares of Quebec City based TSO3 (TSX:TOS), surged yesterday after their earnings call left investor...

Analysts rkn

Redknee’s Q3 revenue could surprise to the upside, says Clarus

August 5, 2014

Because of multiple upgrades and contract renewals, Redknee’s (TSX:RKN) third quarter revenue ...

Analysts esp

Espial gets Buy rating, $4.25 target from Haywood

August 5, 2014

Espial (TSX:ESP) is staring down a “considerable” opportunity in the disruption of the c...

Analysts

Kinaxis is an undervalued leader in the SCM space, says Cormark

August 1, 2014

Kinaxis (TSX:KXS) is a disruptor in the Supply Chain Management space, says Cormark analyst Richard ...

Analysts Tech Triangle OTC

OpenText organic growth plan still a wait-and-see proposition, says Cantor

July 31, 2014

OpenText (TSX:OTC), which has grown primarily through acquisition, is in the midst of refocusing its...

Analysts Software gib.a

Look for continued margin improvement at CGI Group, says Paradigm

July 31, 2014

Improved margins in the U.S. market helped drive a good quarter for CGI Group (TSX:GIB.A), and addit...

Analysts RIM bb

BlackBerry is moving from defense to offense, says Cormark analyst Tse

July 30, 2014

BlackBerry’s (TSX:BB) turnaround has been an uphill battle, but the company is now staring dow...

Analysts Wireless win

Wi-LAN’s new focus is improving revenue and margin consistency, says Cantor Fitzgerald

July 30, 2014

A better than expected quarter has led Cantor Fitzgerald Canada analyst Blair Abernethy to raise his...

Analysts Life Sciences

Allergan is a “free option” for investors looking at Valeant, says Paradigm

July 29, 2014

Valeant Pharmaceuticals’ (TSX:VRX) upcoming Q2 may be the first of a number of quarters that s...

Analysts Gaming aya

The street is still underestimating Amaya Gaming, says Global Maxfin’s Garcea

July 29, 2014

With important regulatory approvals from both the gaming industry and the TSX in the bag on its acqu...

Analysts cls

Celestica’s improving margins highlight its Q2 results, says Paradigm

July 25, 2014

Paradigm analyst Gabriel Leung says improved margins in Celestica’s (TSX:CLS) second quarter o...

Analysts sfd

NXT Energy Solutions’ future looks bright, says Mackie Research Capital

July 24, 2014

After some unavoidable regulatory delays and technical reviews, the future is looking bright for NXT...

Analysts gib.a

CGI Group is still undervalued, says Cormark analyst Tse

July 24, 2014

The valuation gap between CGI Group (TSX:GIB.A) and its more expensively priced peers will begin to ...

Analysts esp

Espial gets buy rating and $4.00 target from Clarus analyst Ofir

July 23, 2014

A major shift in the way cable is being delivered and consumed is creating a huge opportunity for Es...

Analysts xx

Following soft Q1, Paradigm maintains buy rating on Avante Logixx

July 23, 2014

Avante Logixx’s (TSX:XX) Q1 revenue decline is disappointing, but the company’s acquisit...

Analysts tcs

Paradigm launches coverage of Tecsys with a Buy rating, $10.00 target

July 22, 2014

There is a multi-billion dollar market opportunity in automating the healthcare supply chain and Tec...

Analysts vxs

Clarus launches coverage of ViXS with Buy rating, $3.30 target

July 22, 2014

The 4K TV market represents “a significant opportunity” and Toronto’s ViXs Systems...

Analysts

TRENDING

Will pot stocks rebound in 2026?

Here’s what National Bank thinks of Air Canada right now

Could WELL Health acquire Telus Health?

Is it time to dump your Tilray stock?

Tantalus Systems named “Top Pick” for 2026 at Haywood